| Estrogen receptor-positive (ER+) breast cancer treatment: Are multi-target compounds the next promising approach? CF Almeida, A Oliveira, MJ Ramos, PA Fernandes, N Teixeira, C Amaral Biochemical Pharmacology 177, 113989, 2020 | 51 | 2020 |
| Cannabinoids in breast cancer: differential susceptibility according to subtype CF Almeida, N Teixeira, G Correia-da-Silva, C Amaral Molecules 27 (1), 156, 2021 | 27 | 2021 |
| Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors C Amaral, FM Trouille, CF Almeida, G Correia-da-Silva, N Teixeira The Journal of steroid biochemistry and molecular biology 210, 105876, 2021 | 23 | 2021 |
| Discovery of a multi-target compound for estrogen receptor-positive (ER+) breast cancer: Involvement of aromatase and ERs CF Almeida, N Teixeira, A Oliveira, TV Augusto, G Correia-da-Silva, ... Biochimie 181, 65-76, 2021 | 18 | 2021 |
| The anti-cancer potential of crotoxin in estrogen receptor-positive breast cancer: Its effects and mechanism of action CF Almeida, C Amaral, TV Augusto, G Correia-da-Silva, CM de Andrade, ... Toxicon 200, 69-77, 2021 | 16 | 2021 |
| Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells TV Augusto, C Amaral, CF Almeida, N Teixeira, G Correia-da-Silva Molecular and cellular endocrinology 537, 111426, 2021 | 11 | 2021 |
| An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER+) Breast Cancer: Effects on … C Amaral, G Correia-da-Silva, CF Almeida, MJ Valente, C Varela, ... Molecules 28 (2), 789, 2023 | 8 | 2023 |
| Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors CF Almeida, N Teixeira, MJ Valente, AM Vinggaard, G Correia-da-Silva, ... Cancers 15 (9), 2517, 2023 | 5 | 2023 |
| In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment PHA Bezerra, C Amaral, CF Almeida, G Correia-da-Silva, MR Torqueti, ... Molecules 28 (13), 4893, 2023 | 4 | 2023 |
| Effects of PI3K inhibition in AI-resistant breast cancer cell lines: Autophagy, apoptosis, and cell cycle progression TV Augusto, C Amaral, Y Wang, S Chen, CF Almeida, N Teixeira, ... Breast Cancer Research and Treatment 190, 227-240, 2021 | 3 | 2021 |
| Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies CF Almeida, G Correia-da-Silva, N Teixeira, C Amaral Biochemical Pharmacology, 116178, 2024 | | 2024 |
| Tamoxifen bisphenol: a modulator of ERβ in estrogen receptor-positive breast cancer C Almeida, T Augusto, A Oliveira, G Correia-da-Silva, MJ Ramos, ... MDPI, 2020 | | 2020 |
